These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
730 related items for PubMed ID: 19281808
1. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats. Lahiri S, Sen T, Palit G. Eur J Pharmacol; 2009 May 01; 609(1-3):118-25. PubMed ID: 19281808 [Abstract] [Full Text] [Related]
2. Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties. Brzozowski T, Konturek PC, Pajdo R, Kwiecień SN, Konturek S, Targosz A, Burnat G, Cieszkowski J, Pawlik WW, Hahn EG. Inflammopharmacology; 2005 May 01; 13(1-3):317-30. PubMed ID: 16259750 [Abstract] [Full Text] [Related]
3. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats. Konturek PC, Brzozowski T, Burnat G, Szlachcic A, Koziel J, Kwiecien S, Konturek SJ, Harsch IA. J Physiol Pharmacol; 2010 Aug 01; 61(4):429-36. PubMed ID: 20814070 [Abstract] [Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells. Ohama Y, Harada T, Iwabe T, Taniguchi F, Takenaka Y, Terakawa N. Fertil Steril; 2008 Feb 01; 89(2):311-7. PubMed ID: 17555752 [Abstract] [Full Text] [Related]
5. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat. Konturek PC, Brzozowski T, Kania J, Kukharsky V, Bazela K, Kwiecien S, Harsch I, Konturek SJ, Hahn EG. Scand J Gastroenterol; 2003 May 01; 38(5):468-76. PubMed ID: 12795455 [Abstract] [Full Text] [Related]
6. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway. Hung SH, Yeh CH, Huang HT, Wu P, Ho ML, Chen CH, Wang C, Chao D, Wang GJ. Life Sci; 2008 Mar 12; 82(11-12):561-9. PubMed ID: 18272184 [Abstract] [Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R. Shock; 2009 Sep 12; 32(3):317-24. PubMed ID: 19174742 [Abstract] [Full Text] [Related]
8. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway. Zhang HL, Xu M, Wei C, Qin AP, Liu CF, Hong LZ, Zhao XY, Liu J, Qin ZH. Neuroscience; 2011 Mar 10; 176():381-95. PubMed ID: 21185913 [Abstract] [Full Text] [Related]
12. Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance. Hasegawa H, Takano H, Zou Y, Qin Y, Hizukuri K, Odaka K, Toyozaki T, Komuro I. J Mol Cell Cardiol; 2005 Feb 10; 38(2):257-65. PubMed ID: 15698832 [Abstract] [Full Text] [Related]
13. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, Yoshikawa T, Kitamura N. Eur J Cardiothorac Surg; 2004 Apr 10; 25(4):530-6. PubMed ID: 15037267 [Abstract] [Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts. Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL. Clin Exp Pharmacol Physiol; 2008 Jan 10; 35(1):72-7. PubMed ID: 18047631 [Abstract] [Full Text] [Related]
15. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY. Arthritis Res Ther; 2008 Jan 10; 10(1):R6. PubMed ID: 18199331 [Abstract] [Full Text] [Related]